Charles Wykoff

Scientific Advisor at EyePoint Pharmaceuticals

Dr. Charles Wykoff is Managing Partner of the Retina Consultants of Texas Research Centers; Chairman of the Research and Clinical Trials Committee, Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital. He received his baccalaureate from MIT, Ph.D. from Oxford University while on a Marshall Scholarship, and MD from Harvard Medical School.

Dr. Wykoff completed an ophthalmology residency and vitreoretinal fellowship at Bascom Palmer Eye Institute where he served as Chief Resident/Co-Director of Ocular Trauma and received a Heed Fellowship and the Ronald G. Michels Award.

Dr. Wykoff is passionate about translational research and clinical trial design and serves as principal investigator for numerous clinical trials. He has published nearly 200 peer-reviewed manuscripts and frequently speaks at national and international academic meetings. His research interests pertain to angiogenesis, retinal vascular diseases, atrophic retinal diseases, and vitreoretinal surgical topics. Dr. Wykoff serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late-stage developments.

Timeline

  • Scientific Advisor

    Current role